Masimo Corporation
NASDAQ:MASIMedical - Devices
+$0.00 today
- Market cap
- $9.42B
- Beta
- 1.10
- P/E (TTM)
- 123.1
- EPS (TTM)
- $1.46
Volume 0.00M
Average 1.08M
MASI Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Masimo CorporationNASDAQ: MASI
Accounts Receivables · Q1 FY2026 · quarter ended Apr 2026
Accounts receivables turns positive
Q1 FY2026 accounts receivables was $36.3M, compared with -$4M a year earlier. Trailing-twelve-month accounts receivables was $57.5M.
Context
- Accounts receivables amounted to 1.1% of revenue in FY2025, down 1.7 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near $36.3M or moves back toward the trailing-twelve-month quarterly average of $14.38M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 17.2M USD
- Year-over-year change
- +128.6%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 17.2M | +128.6% |
| FY2024 | 2024-12-28 | (60.2M) | -165.5% |
| FY2023 | 2023-12-31 | 91.9M | +160.7% |
| FY2022 | 2022-12-31 | (151.3M) | -96.7% |
| FY2021 | 2021-12-31 | (76.9M) | — |
Accounts Receivables vs competitors
How MASI compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +214.3% is the 4th highest of 11, against a peer median of +97.8%.
- Accounts receivables amounts to 3.7% of revenue for MASI, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $373M USD | +326.1% | +15.1% | 0.9% | |
| LTM Jun 2026 | $140M USD | +154.5% | +160.7% | 1.0% | |
| LTM Jun 2026 | $96M USD | +21.5% | +40.1% | 0.8% | |
| LTM Jun 2026 | $90.02M USD | +292.6% | +38.3% | 2.3% | |
| LTM Jun 2026 | €59.16M EUR | +4904.7% | — | 4.8% | |
| LTM Apr 2026 | $57.5M USD | +214.3% | — | 3.7% | |
| LTM Jun 2026 | $11.4M USD | +16.3% | — | 0.2% | |
| LTM Jun 2026 | $8.1M USD | +148.2% | — | 0.3% | |
| LTM Sep 2026 | $6.86M USD | -47.0% | +13.3% | 2.4% | |
| FY2025 | €6.76M EUR | +47.3% | +178.8% | — | |
| LTM Jun 2026 | $6.37M USD | -77.2% | +68.4% | 0.8% | |
| Peer median (excluding MASI) | — | +97.8% | +40.1% | 0.9% | |
Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 229.6M | 143.5M | 81.5M | (304.9M) | (151.5M) |
| Depreciation & Amortization | 35.6M | 136.1M | 98.3M | 103M | 38.8M |
| Deferred Income Tax | (15.1M) | (39.3M) | (35.6M) | (38.2M) | 11.8M |
| Stock-Based Compensation | 44.7M | 47.7M | 7M | 41.5M | 35.8M |
| Change in Working Capital | (31.5M) | (261.8M) | (70.9M) | (10.7M) | (89.9M) |
| Accounts Receivables | (76.9M) | (151.3M) | 91.9M | (60.2M) | 17.2M |
| Inventory | 13.5M | (155.9M) | (69.2M) | (7.5M) | (112.1M) |
| Accounts Payables | 11M | 60.5M | (19.6M) | 14.8M | (27.1M) |
| Other Working Capital | 20.9M | (15.1M) | (74M) | 42.2M | 32.1M |
| Other Non-Cash Items | 1.3M | 3.2M | 13.8M | 405.7M | 372.2M |
| Operating Cash Flow | 264.6M | 29.4M | 94.1M | 196.4M | 217.2M |
| Capital Expenditures | (34.9M) | (56.3M) | (87.7M) | (51.1M) | (19.4M) |
| Acquisitions (Net) | 0 | (999.7M) | 7.5M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (12M) | (5.2M) | (44.7M) | (31.2M) | 294.5M |
| Investing Cash Flow | (37.5M) | (1.06B) | (81.2M) | (51.2M) | 275.1M |
| Debt Repayment | 0 | 939.2M | (51.2M) | (146.8M) | (207.8M) |
| Common Stock Issued | 23.2M | 8.1M | 7M | 25.2M | 71.4M |
| Common Stock Repurchased | (128.9M) | (401.5M) | 0 | 0 | (363.7M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (16.7M) | (25.4M) | (12.9M) | (4M) | (20.6M) |
| Financing Cash Flow | (122.4M) | 520.4M | (57.1M) | (125.6M) | (520.7M) |
| Effect of Forex Changes | (1.3M) | (30.9M) | 2.8M | (6.4M) | 53.8M |
| Net Change in Cash | 103.4M | (538.8M) | (41.4M) | 13.2M | 26M |
| Free Cash Flow | 229.7M | (26.9M) | 6.4M | 145.3M | 197.8M |
Masimo Corporation
NASDAQ:MASI
Intrinsic Alpha fair value
Locked
Current Price
$179.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.